Endocrinology News and Research

Latest Endocrinology News and Research

Medicare Advantage plans shift their financial risk to doctors

Dr. Christopher Rao jumped out of his office chair. He'd just learned an elderly patient at high risk of falling was resisting his advice to go to an inpatient rehabilitation facility following a hip fracture.

8 Oct 2018

Researchers discover previously unknown function of key component in the immune system

The complement proteins that circulate in our blood are an important part of our immune system. They help identify bacteria, viruses and other harmful organisms, making it easier for our white blood cells to find and neutralize dangerous microbes.

5 Oct 2018

Scientists call for microbiota vault of healthy bacteria

A team of researchers are gathering bacteria from across the world to create a microbiota vault containing healthy bacteria from the human gut and skin.

5 Oct 2018

Vitamin D supplements do not improve bone health, concludes study

Despite recommendations from governmental bodies around the world, vitamin D supplements do not benefit bone health. The conclusion follows one of the largest reviews ever of vitamin D.

5 Oct 2018

New DNA tool can predict people's height and potentially assess risk for serious illnesses

A new DNA tool created by Michigan State University can accurately predict people's height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.

5 Oct 2018

Length of hospital stay and readmission likelihood increases by 2.9% in rural areas, review finds

Hospital readmissions cost hospitals about $26 billion annually. Systems like the Hospital Readmission Reduction Program within the Affordable Care Act penalize hospitals with higher readmission rates for targeted diagnoses.

5 Oct 2018

Study reveals factors linked to the development of Crohn's disease

How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry.

5 Oct 2018

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.

5 Oct 2018

Tarragon and bitter melon supplements may be less helpful for women than men

Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist.

5 Oct 2018

New approach could lead to precise treatments for traumatic brain injury

Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

5 Oct 2018

New report provides overview of cancer risk among U.S. Hispanics/Latinos

The cancer burden in Puerto Rico, a U.S. territory with a 99% Hispanic population, is substantially different from that of Hispanics in the continental U.S., according to Cancer Statistics for Hispanics/Latinos, 2018.

4 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

Discovery opens door to new therapies for type 1 diabetes

Researchers at St Vincent’s Institute in Melbourne have identified a key target of the immune response that causes type 1 diabetes.

4 Oct 2018

Yo-yo dieting increases risk of heart attack and stroke, finds study

In the study, sudden changes in metabolic health parameters were associated with a raised risk of heart attacks, strokes and even early deaths.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

The Neurobiotechnology research team of the Universitat Jaume I in Castellón, Spain, headed by professor Ana María Sánchez, has proven the positive effects of a vegetable hormone, helping reverse brain alterations caused by high-fat diets, type-2 diabetes, obesity and physical inactivity.

3 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Endocrinology News and Research

Latest Endocrinology News and Research

Medicare Advantage plans shift their financial risk to doctors

Researchers discover previously unknown function of key component in the immune system

Scientists call for microbiota vault of healthy bacteria

Vitamin D supplements do not improve bone health, concludes study

New DNA tool can predict people's height and potentially assess risk for serious illnesses

Length of hospital stay and readmission likelihood increases by 2.9% in rural areas, review finds

Study reveals factors linked to the development of Crohn's disease

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Tarragon and bitter melon supplements may be less helpful for women than men

New approach could lead to precise treatments for traumatic brain injury

New report provides overview of cancer risk among U.S. Hispanics/Latinos

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Discovery opens door to new therapies for type 1 diabetes

Yo-yo dieting increases risk of heart attack and stroke, finds study

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Newly discovered compounds may explain whole grain health benefits

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Endocrinology News and Research

Latest Endocrinology News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in